Pharma teachers faking profiles at multiple institutions, face being blacklisted

New Delhi: In what has alarmed the government, the Pharmacy Council of India (PCI) has found widespread data faking on the government’s DIGI-PHARMed portal for teachers.

As many as 45,355 cases of duplicate or invalid profile details have been registered on the portal.

There are more than 42,000 pharmacy colleges in India with around 11.2 million pharmacists being registered with the council.

Pharmacists are at the forefront of healthcare, often serving as the first point of contact for individuals seeking health advice or primary care. Their roles extend far beyond merely dispensing medications.

In a recent meeting, the pharmacy education regulator was made aware about many pharmacists creating fake profiles using the same Aadhaar or PAN number, and working as faculty in multiple institutions.

Taking cognizance of this fraudulent activity, the council has decided to blacklist these fake faculty and debar them permanently if found guilty a second time.

“Council has analyzed that many pharmacists have created duplicate profiles with the same Aadhaar number or PAN number. In addition to this, all these duplicate profiles on a single Aadhaar number were found working as a faculty in different institutions,” said Anil Mittal, registrar-cum-secretary, PCI, in a communication to the registered pharmacists, state pharmacy councils and approved pharmacy institutions.

The council said that these pharmacists have entered invalid/fake Aadhaar or PAN card details during the registration on DIGI-PHARMed Portal, including Aadhaar numbers having more or less than 12 digits.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices